Literature DB >> 15219996

The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction.

Anne F McGettrick1, Luke A J O'Neill.   

Abstract

Toll-like receptors (TLRs) play an essential role in the detection and elimination of invading microbes. They are type-1 transmembrane receptors, containing extracellular leucine rich repeats and an intracellular Toll/interleukin-1 receptor (TIR) domain. Upon stimulation, these receptors interact with specific TIR domain-containing adaptor proteins. Five such adaptors have been discovered to date, MyD88, Mal (MyD88 adaptor-like)/TIRAP (TIR domain-containing adaptor protein), Trif (TIR-domain-containing adaptor inducing interferon-beta), TRAM (Trif-related adaptor molecule) and SARM (SAM and ARM-containing protein). Different TLRs use different combinations of these adaptors, leading to the activation of common and unique pathways involved in the elimination of the invading microbe.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219996     DOI: 10.1016/j.molimm.2004.04.006

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  42 in total

Review 1.  Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression.

Authors:  Thomas Hamilton; Xiaoxia Li; Michael Novotny; Paul G Pavicic; Shyamasree Datta; Chenyang Zhao; Justin Hartupee; Dongxu Sun
Journal:  J Leukoc Biol       Date:  2011-12-13       Impact factor: 4.962

2.  Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus.

Authors:  Even Walseng; Kazuyuki Furuta; Romina S Goldszmid; Karis A Weih; Alan Sher; Paul A Roche
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

Review 3.  Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.

Authors:  Akira Andoh; Yoshihide Fujiyama
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

4.  A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis.

Authors:  Thomas R Hawn; Sarah J Dunstan; Guy E Thwaites; Cameron P Simmons; Nguyen Thuong Thuong; Nguyen Thi Ngoc Lan; Hoang Thi Quy; Tran Thi Hong Chau; Nguyen T Hieu; Stephanie Rodrigues; Marta Janer; Lue Ping Zhao; Tran Tinh Hien; Jeremy J Farrar; Alan Aderem
Journal:  J Infect Dis       Date:  2006-09-12       Impact factor: 5.226

5.  Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP.

Authors:  Girish K Radhakrishnan; Qiqi Yu; Jerome S Harms; Gary A Splitter
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

Review 6.  How metabolism generates signals during innate immunity and inflammation.

Authors:  Anne F McGettrick; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2013-06-24       Impact factor: 5.157

7.  Small Molecule Mimetics of α-Helical Domain of IRAK2 Attenuate the Proinflammatory Effects of IL-33 in Asthma-like Mouse Models.

Authors:  Jinghong Li; Kunio Saruta; Justin P Dumouchel; Jenna M Magat; Joanna L Thomas; Dariush Ajami; Mitra Rebek; Julius Rebek; Timothy D Bigby
Journal:  J Immunol       Date:  2018-05-04       Impact factor: 5.422

8.  Mycobacterium bovis bacillus Calmette-Guerin induces CCL5 secretion via the Toll-like receptor 2-NF-kappaB and -Jun N-terminal kinase signaling pathways.

Authors:  Patricia Méndez-Samperio; Artemisa Trejo; Aline Pérez
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

9.  Innate immune recognition of Yersinia pseudotuberculosis type III secretion.

Authors:  Victoria Auerbuch; Douglas T Golenbock; Ralph R Isberg
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

10.  Domain architecture evolution of pattern-recognition receptors.

Authors:  Qing Zhang; Christian M Zmasek; Adam Godzik
Journal:  Immunogenetics       Date:  2010-03-02       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.